• Source: Scopus
  • Calculated based on number of publications stored in Pure and citations from Scopus
20042022

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Overview

Bonny is an Associate Professor at MUCHE (2022-). Previously she was a Senior Researcher at MUCHE (2015-2021), and a Research Fellow at the Centre for Health Economics, Research and Evaluation at the University of Technology Sydney (UTS) (2009-2015). She has also worked at AstraZeneca in the United Kingdom as a senior health economist, Access Economics in Canberra as a senior economist, and the Social Policy Evaluation and Research Centre at the Australian National University as an Assistant researcher.

Experience

Bonny’s expertise is in pharmaceutical policy in Australia, researching economic evaluation of healthcare interventions and technologies methodology, and analysing linked administrative data to inform economic evaluations. She currently co-leads a team of researchers conducting evaluations of submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) and researching economic evaluation methodology. She has been involved in over 40 evaluations of submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) since 2009, and has also conducted evaluations of submissions to the Medical Services Advisory Committee (MSAC) and the National Diabetes Subsidy Scheme (NDSS). For this work she was awarded the UTS Research Excellence Through Partnership award in 2013. 

To date, she has been the recipient of career research funding of over $22.0 million spread over 16 grants and has 32 peer-reviewed journal articles.

She was a member of the Ezetimibe Review Reference Group for the Australian Government Department of Health (2016-2017), and is currently a member of the NSW Cancer Council’s Pathways Scientific Advisory Committee on Colorectal Cancer and Lynch Syndrome (2018 -) and the Australian Clinical Trials Alliance Health Economics Alongside Trials Special Interest Group (ACTA HEAT SIG). She is currently on the editorial board of Pharmacoeconomics, and is an associate editor of Oxford Open Economics.

Her PhD was on “Pharmaceutical Policy in Australia: Developing Methods to Manage Uncertainty in Health Technology Assessment”, for which she received the UTS Chancellor’s List award in 2016.

Bonny was also an executive member of the Australian Health Economics Society (AHES) committee (2012-2016). In 2015-2016 she was acting secretary and was involved with organising the 2015 AHES conference and co-organising the 2017 AHES conference in Sydney. In 2013 and 2014, Bonny co-conceived and co-organised the first and second Australian Health Economics Doctoral workshop. The feedback from participants was very positive in the first two years that the workshop is now a permanent fixture of the annual Australian Health Economics Society conference.

Bonny has excellent skills in presenting complex economic research in ways that captivates an audience’s attention and is understandable. She teaches health economics as part of the Masters of Public Health (2017-) and regularly teaches short courses on economic evaluation.

Education/Academic qualification

Health Economics, Doctor of philosophy

20112014

Award Date: 1 Jan 2015

Health Economics, Master of Science, University of York

20062007

Award Date: 1 Jan 2008

Economics, Econometrics, Bachelor of Economics (Honours), Australian National University

19992002

Award Date: 1 Jan 2003

Fingerprint

Dive into the research topics where Bonny Parkinson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Network

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or